Cytomed Therapeutics six-month loss narrows to S$1.79m
Cytomed Therapeutics posted a loss of S$1.79 million for the six months ended June 30, 2026, narrowing from S$2.25 million in the prior year. Revenue rose to S$157,289 from S$155,887.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Cytomed Therapeutics H1 2026 net loss narrows 20.1% to S$1.79m
Cytomed Therapeutics reported a net loss of S$1.79 million for the six months ended June 30, 2026, a 20.1% decrease from the prior year, driven by lower other expenses, including consultancy costs, and gains on forex and warrant liabilities. Other income declined due to lower interest and research income.